These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
    Author: Vallejo J, Olivares J, Marcos T, Bulbena A, Menchón JM.
    Journal: Br J Psychiatry; 1992 Nov; 161():665-70. PubMed ID: 1422616.
    Abstract:
    A double-blind clinical trial of clomipramine versus phenelzine was carried out on 30 patients suffering from DSM-III obsessive-compulsive disorder. The study period was 12 weeks, and the maximum doses used (from the fifth week on) were 225 mg/day for clomipramine (14 patients) and 75 mg/day for phenelzine (12 patients); four patients dropped out. Obsessive symptoms improved significantly in both drug groups, but there was no significant difference between groups. Depressive symptoms improved before obsessive ones.
    [Abstract] [Full Text] [Related] [New Search]